|
EP2298900A1
(en)
|
1996-09-17 |
2011-03-23 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating intracellular diseases
|
|
EP2261352A3
(en)
|
1998-05-01 |
2012-01-04 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
|
CA2360667A1
(en)
|
1999-01-22 |
2000-07-27 |
Smithkline Beecham Biologicals S.A. |
Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof
|
|
CA2365102A1
(en)
|
1999-03-12 |
2000-09-21 |
Smithkline Beecham Biologicals S.A. |
Neisseria meningitidis antigenic polypeptides and encoding polynucleotides and uses thereof
|
|
JP2003518363A
(ja)
|
1999-04-30 |
2003-06-10 |
カイロン エセ．ピー．アー． |
保存されたナイセリア抗原
|
|
EP2270173B1
(en)
|
1999-05-19 |
2016-01-06 |
GlaxoSmithKline Biologicals SA |
Combination neisserial compositions
|
|
RU2281956C2
(ru)
|
1999-10-29 |
2006-08-20 |
Чирон С.Р.Л. |
Антигенные пептиды neisseria
|
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
PT2289545T
(pt)
|
2000-01-17 |
2016-09-06 |
Glaxosmithkline Biologicals Sa |
Vacina de omv suplementada contra meningococos
|
|
PL216780B1
(pl)
|
2000-01-25 |
2014-05-30 |
Univ Queensland Of Santa Lucia |
Wyizolowane białka zawierające konserwatywne obszary antygenu powierzchniowego NhhA z Neisseria meningitidis, białka fuzyjne, kompozycja farmaceutyczna, przeciwciało monoklonalne lub wiążący antygen fragment przeciwciała monoklonalnego, wyizolowany kwas nukleinowy, konstrukt ekspresyjny, komórka gospodarza, sposób wytwarzania rekombinowanego białka, sposób wykrywania N. meningitidis w próbce biologicznej, sposób diagnozowania zakażenia N. meningitidis oraz sposób wykrywania N. meningitidis w próbce biologicznej uzyskanej od pacjenta oraz zastosowanie wyizolowanego białka, białka fuzyjnego i konstruktu ekspresyjnego
|
|
ES2281409T3
(es)
|
2000-02-28 |
2007-10-01 |
Novartis Vaccines And Diagnostics S.R.L. |
Expresion heterologa de proteinas de neisseria.
|
|
GB0011108D0
(en)
*
|
2000-05-08 |
2000-06-28 |
Microscience Ltd |
Virulence gene and protein and their use
|
|
US6936261B2
(en)
|
2000-07-27 |
2005-08-30 |
Children's Hospital & Research Center At Oakland |
Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
|
|
GB0107219D0
(en)
*
|
2001-03-22 |
2001-05-16 |
Microbiological Res Authority |
Immunogenic commensal neisseria sequences
|
|
GB0108024D0
(en)
*
|
2001-03-30 |
2001-05-23 |
Chiron Spa |
Bacterial toxins
|
|
CN1306956C
(zh)
*
|
2001-04-17 |
2007-03-28 |
希龙公司 |
诱导功能活性抗体的脑膜炎球菌b抗原表位的分子模拟物
|
|
RU2355704C2
(ru)
*
|
2001-04-17 |
2009-05-20 |
Новартис Вэксинс Энд Диагностикс, Инк |
Моноклональное антитело, направленное против gna33 пептида, и его применение
|
|
CU23245A1
(es)
|
2001-07-16 |
2007-10-17 |
Inst De Medicina Tropical Pedr |
CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
BR0211494A
(pt)
|
2001-07-27 |
2004-08-17 |
Chiron Srl |
Adesinas de meningococo nada, app e orf 40
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
EP1495039A4
(en)
*
|
2002-03-20 |
2006-07-26 |
Univ Emory |
MUTANTS OF NEISSERIA, LIPOOLIGOSACCHARIDES AND IMMUNOGENIC COMPOSITIONS
|
|
EP1524991A1
(en)
*
|
2002-08-02 |
2005-04-27 |
GlaxoSmithKline Biologicals S.A. |
Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
|
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
HUE031886T2
(en)
|
2002-10-11 |
2017-08-28 |
Glaxosmithkline Biologicals Sa |
Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
|
|
US7807802B2
(en)
|
2002-11-12 |
2010-10-05 |
Abbott Lab |
Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
ES2461350T3
(es)
*
|
2003-01-30 |
2014-05-19 |
Novartis Ag |
Vacunas inyectables contra múltiples serogrupos de meningococos
|
|
CU23237A1
(es)
*
|
2003-12-03 |
2007-09-26 |
Ct Ingenieria Genetica Biotech |
PROTEINA NMB1125 Y SU USO EN FORMULACIONES FARMACéUTICAS
|
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
ES2616294T3
(es)
|
2005-01-27 |
2017-06-12 |
Children's Hospital & Research Center At Oakland |
Vacunas de vesículas basadas en GNA1870 para protección de amplio espectro contra enfermedades provocadas por Neisseria meningitidis
|
|
NZ599345A
(en)
|
2005-02-18 |
2013-07-26 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic Escherichia Coli
|
|
AU2006214064B2
(en)
|
2005-02-18 |
2012-04-26 |
J. Craig Venter Institute, Inc. |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
|
AU2006220772A1
(en)
*
|
2005-03-04 |
2006-09-14 |
Verenium Corporation |
Nucleic acids and proteins and methods for making and using them
|
|
CU23578A1
(es)
|
2005-09-16 |
2010-09-30 |
Ct Ingenieria Genetica Biotech |
Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
CU23549A1
(es)
*
|
2005-12-29 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Composiciones farmacéuticas que contienen la proteína nma0939
|
|
CA2656474A1
(en)
|
2006-06-29 |
2008-01-03 |
Novartis Ag |
Polypeptides from neisseria meningitidis
|
|
WO2008020330A2
(en)
|
2006-08-16 |
2008-02-21 |
Novartis Ag |
Immunogens from uropathogenic escherichia coli
|
|
CU23630A1
(es)
|
2006-10-30 |
2011-02-24 |
Ct Ingenieria Genetica Biotech |
Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
CN102356089B
(zh)
|
2008-02-21 |
2014-02-19 |
诺华股份有限公司 |
脑膜炎球菌fHBP多肽
|
|
HUE049695T2
(hu)
|
2009-03-24 |
2020-10-28 |
Glaxosmithkline Biologicals Sa |
Adjuváló H meningococcus faktort kötõ fehérje
|
|
WO2010130896A2
(fr)
|
2009-05-14 |
2010-11-18 |
Sanofi Pasteur |
Procédé pour adjuver le lipopolysaccharide (lps) des bactéries à gram-négatif
|
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
KR101594228B1
(ko)
|
2010-08-23 |
2016-02-15 |
와이어쓰 엘엘씨 |
네이세리아 메닌기티디스 ｒＬＰ２０８６ 항원의 안정한 제제
|
|
NZ607224A
(en)
|
2010-09-10 |
2014-11-28 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
|
BR112013005626B1
(pt)
|
2010-09-10 |
2022-07-26 |
Glaxosmithkline Biologicals Sa |
Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição
|
|
MX359256B
(es)
|
2012-03-09 |
2018-09-19 |
Pfizer |
Composiciones de neisseria meningitidis y metodos de las mismas.
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
MX357538B
(es)
|
2012-06-14 |
2018-07-13 |
Novartis Ag |
Vacunas para meningococo de serogrupo x.
|
|
AU2013295242C1
(en)
|
2012-07-27 |
2018-08-09 |
Institut National De La Sante Et De La Recherche Medicale |
CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
|
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
RU2662968C2
(ru)
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
|
AU2016221318B2
(en)
|
2015-02-19 |
2020-06-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
WO2017137085A1
(en)
|
2016-02-11 |
2017-08-17 |
Sanofi Pasteur |
Meningitidis vaccines comprising subtilinases
|
|
AU2018215585B2
(en)
|
2017-01-31 |
2022-03-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
EP3622080B1
(en)
*
|
2017-05-10 |
2024-03-27 |
Global Bioenergies |
Improved methods for producing isobutene from 3-methylcrotonic acid
|
|
BR112020001255A2
(pt)
|
2017-07-21 |
2020-07-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
composições imunogênicas de neisseria meningitidis
|
|
US20220081707A1
(en)
*
|
2018-07-25 |
2022-03-17 |
The Trustees Of Indiana University |
Diagnostic assay for a strain of neisseria meningitidis
|
|
EP4034157A1
(en)
|
2019-09-27 |
2022-08-03 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
CN113136444B
(zh)
*
|
2021-05-10 |
2024-04-19 |
临沂大学 |
医用食品中海氏肠球菌的微滴数字pcr检测方法
|
|
CN116162140B
(zh)
*
|
2022-07-19 |
2025-09-09 |
四川大学华西医院 |
一种幽门螺杆菌重组抗原蛋白SecG及其制备方法与应用
|
|
WO2025006737A1
(en)
|
2023-06-30 |
2025-01-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genetically detoxified mutant of neisseria and outer membrane vesicle (omv) vaccine
|
|
CN119792505A
(zh)
*
|
2023-10-10 |
2025-04-11 |
康希诺生物股份公司 |
一种抗脑膜炎球菌的免疫组合物及其用途
|